Loading data
AVGONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 63.89 bn USD | 51.57 bn USD | 35.82 bn USD | 33.2 bn USD |
| Cost of revenue | 20.59 bn USD | 19.07 bn USD | 11.13 bn USD | 11.11 bn USD |
| Gross profit | 43.29 bn USD | 32.51 bn USD | 24.69 bn USD | 22.1 bn USD |
| Research and development expense | 10.98 bn USD | 9.31 bn USD | 5.25 bn USD | 4.92 bn USD |
| Selling, general and administrative expense | 4.21 bn USD | 4.96 bn USD | 1.59 bn USD | 1.38 bn USD |
| Operating profit | 25.48 bn USD | 13.46 bn USD | 16.21 bn USD | 14.23 bn USD |
| Interest expense | — | 3.95 bn USD | 1.62 bn USD | 1.74 bn USD |
| Profit before tax | 22.73 bn USD | 9.92 bn USD | 15.1 bn USD | 12.43 bn USD |
| Income tax expense | -397 m USD | 3.75 bn USD | 1.02 bn USD | 939 m USD |
| Net income (reported basis) | 23.13 bn USD | 5.9 bn USD | 14.08 bn USD | 11.5 bn USD |
| Net income attributable to common shareholders | — | 5.9 bn USD | 14.08 bn USD | 11.22 bn USD |
| Basic earnings per share | 4.91 USD/share | 1.27 USD/share | 3.39 USD/share | 2.74 USD/share |
| Diluted earnings per share | 4.77 USD/share | 1.23 USD/share | 3.3 USD/share | 2.65 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.